sur AI/ML Innovations Inc. (CVE:AIML)
AI/ML Innovations Inc. Appoints Peter Kendall as President and Chief Commercialization Officer
AI/ML Innovations Inc. has announced the appointment of Peter Kendall as its new President and Chief Commercialization Officer, effective January 6, 2025. Kendall, who has held leadership roles at TELUS Health, Medisys, Lifemark, and 3M, brings significant expertise in revenue generation and strategic planning.
Kendall's appointment aligns with AIML's strategic vision to expand its footprint in the health tech industry globally. His track record in scaling businesses and optimizing operations positions him to lead AIML towards impactful growth and innovation.
Kendall's compensation includes a mix of cash and shares, totaling $120,000, along with stock options for 2,500,000 shares. The shares and options are subject to the necessary regulatory approvals.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AI/ML Innovations Inc.